Drugs & Pharmaceuticals

News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.

I'm sure seeing a lot of vaccine disquietude going around in the past few months.
April Fool's Day is seven months away. Otherwise, I'm betting that most of you would write this off as just another joke article. Don't.
Ivermectin is a wonderful drug. So effective that its discovery deserved the 2015 Nobel Prize in Medicine and Physiology awarded to Japanese chemist Satoshi Omura and American parasitologist William Campbell.
Back in February, when I got my second Covid shot in Manhattan, I never would have guessed that I'd be heading over to CVS for a booster. But that's just what happened last week.
“A groundbreaking preprint paper by the prestigious Oxford University Clinical Research Group … includes alarming findings devastating to the COVID vaccine rollout,” Children's Health Defense (CHD) 
The great divide of "vaccine vs. no vaccine" has just grown wider.
Back in March, I gave an update on the progress of otenaproxesul (aka ATB-346), an experimental hydrogen sulfide-based NSAI
It's not at all surprising that CDC data from 2020 shows an increase in drug overdose deaths.
While effective vaccines are an incredibly important part of the COVID-19 solution, none are completely effective, and so we do need 
As Professor Katherine Radtke-Seley and I wrote last year in the Baltimore Sun, vaccines